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Cytokine-activated  neutrophils  are  known  to  be  essential  for  protection  against  group  A 
Streptococcus  infections.  However,  during  severe  invasive  group  A  Streptococcus  infections 
that are accompanied by neutropenia, it remains unclear which factors are protective against 
such infections, and which cell population is the source of them. Here we show that mice 
infected with severe invasive group A Streptococcus isolates, but not with non-invasive group A 
Streptococcus isolates, exhibit high concentrations of plasma interferon-γ during the early stage 
of infection. Interferon-γ is necessary to protect mice, and is produced by a novel population 
of granulocyte–macrophage colony-stimulating factor-dependent immature myeloid cells with 
ring-shaped nuclei. These interferon-γ-producing immature myeloid cells express monocyte 
and granulocyte markers, and also produce nitric oxide. The adoptive transfer of interferon- 
γ-producing  immature  myeloid  cells  ameliorates  infection  in  wild-type  and  interferon- 
γ-deficient mice. our results indicate that interferon-γ-producing immature myeloid cells have 
a protective role during the early stage of severe invasive group A Streptococcus infections. 
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S
treptococcus pyogenes (group A Streptococcus; GAS) is one of 
the most common human pathogens. It causes a wide vari-
ety of infections, ranging from uncomplicated pharyngitis and 
skin infections to severe and even life-threatening manifestations 
such as streptococcal toxic shock syndrome (STSS) and necrotiz-
ing fasciitis. The mortality rates for STSS and necrotizing fasciitis 
are high (30–70%), even following prompt antibiotic therapy and 
debridement1–4.
It is widely believed that myeloid cells including polymorphonu-
clear leukocytes (PMNs) have a central role in survival from GAS 
infections, and interferon (IFN)-γ is essential to full activation and 
proper function of PMNs. Notably, IFN-γ at the infection site is 
thought to be critical for protection; however, its increased systemic 
levels  seem  to  be  detrimental  to  survival  after  GAS  infections5. 
Therefore, the appropriate regulation of cytokine-producing cells 
may be critical for survival and host defense against severe invasive 
GAS infections.
Myeloid cells with ring-shaped nuclei (ring cells) are present in 
the peripheral blood of patients with myeloproliferative diseases, 
but only rarely in healthy control subjects6,7. Ring cells are usually 
referred to as PMNs. However, not only Gr-1high PMN-like ring 
cells, but also Gr-1low mononuclear cell-like ring cells are present in 
the bone marrow, peripheral blood, and inflammatory infiltrates of 
mice8. Morphologically, a part of myeloid-derived suppressor cells 
(MDSCs) has ring-shaped nuclei9,10. MDSCs are potent suppressors 
of T-cell immunity, and their presence is associated with a poor clin-
ical outcome in cancer. They are divided into 2 subtypes according 
to morphology and surface markers: Ly-6G −  Ly-6Chigh monocytic 
MDSCs and  Ly-6G +  Ly-6Clow granulocytic  MDSCs11,12. Recent 
studies have demonstrated the considerable suppressive potential 
of MDSCs on T-cell immunity in autoimmune diseases, and also   
in  chronic  infections  with  intracellular  pathogens,  such  as   
Salmonella typhimurium, Candida albicans, Trypanosoma cruzi, and 
Toxoplasma gondii13. However, the biological functions of ring cells 
in infectious diseases, and also the relationship between ring cells 
and MDSCs, remain largely unknown.
In the present study, IFN-γ-producing immature myeloid cells 
with ring-shaped nuclei (γIMCs), which originated from bone mar-
row precursor-like cells (BMPCs), are shown to be functionally and 
phenotypically distinct from MDSCs. We demonstrate that γIMCs 
have a protective role against severe invasive GAS infections, and 
possibly compensate for neutropenia.
Results
Role of IFN-γ in severe invasive GAS infections. To clarify the 
types of cytokines involved in severe invasive GAS infections, we 
first investigated the dynamics of cytokines in severe invasive and 
non-invasive GAS infections. As a model of disseminated infection 
in normally sterile sites, we intraperitonially (i.p.) infected GAS-
susceptible C3H/HeN mice14–17 with either severe invasive (emm3 
genotype rgg gene-mutated STSS strain, NIH34) or non-invasive 
(emm3 genotype non-STSS (pharyngitis) strain, K33) GAS clinical 
isolates18, and measured the levels of plasma cytokines. We detected 
no significant amount of plasma cytokines within 24 h of infection. 
By contrast, in mice infected with severe invasive GAS isolates, but 
not with non-invasive GAS isolates, we detected high levels of plasma 
IFN-γ; moreover, the levels increased rapidly at 48 h post-infection 
(Fig. 1a). Other cytokines, such as IL-1α, IL-1β, IL-4, IL-5, IL-12 
p70 and IL-17, were scarcely detected in the plasma of mice infected 
with either severe invasive or non-invasive isolates. By contrast, in 
mice infected with severe invasive GAS isolates, the levels of IL-2, 
IL-10, and TNF increased transiently at 36 h post-infection.
Further, we evaluated whether IFN-γ is the host factor contrib-
uting to protection against severe invasive GAS infections, or to 
deterioration of STSS through an augmented inflammatory process. 
We i.p. administered mice with an anti-mouse IFN-γ neutralizing 
mAb (clone R4-6A2), on the day of infection with severe invasive   
GAS isolates. At 72 h post-infection, all of the mice administered 
with the IFN-γ neutralizing mAb died. By contrast, 50% of the mice 
treated with rat IgG as a control survived (Fig. 1b). These results are 
consistent with those of a previous study5, in which mice treated 
with a different IFN-γ neutralizing mAb (clone XMG1.2) and IFN-γ 
knockout (Ifng − / − ) mice were more susceptible to lethal skin infec-
tion with the M-nontypeable GAS strain 64/14 than were control 
IgG-administered  mice  and  wild-type  mice,  respectively.  Thus, 
IFN-γ may act as a host defense factor against severe invasive GAS 
infections.
A source of IFN-γ in severe invasive GAS infections. It is widely 
believed that T cells are a main source of IFN-γ in severe invasive 
GAS infections19–21. To identify the IFN-γ-producing cell types in 
mice infected with severe invasive GAS isolates, we used an in vivo 
intracellular  cytokine  synthesis  (ICS)  assay22,23  to  assess  splenic 
IFN-γ production at 48 h post-infection. Unexpectedly, we revealed 
that Gr-1 +  CD11b +  cells (but not TCR-β +  TCR-γ/δ + , CD4 + , or 
CD8 +  T cells, DX5 +  NK/NKT cells, or CD11c +  MHC-II +  dendritic 
cells) were a source of splenic IFN-γ in superantigen-insensitive   
C57BL/6 mice24,25, and also in C3H/HeN mice (Fig. 2a and b). These   
Gr-1 +  cells appeared in the spleen on day 1 post-infection, subse-
quently increased in number, and were the major source of IFN-γ 
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Figure 1 | IFN- is a host defense factor in mice infected with severe 
invasive GAS isolates. (a) C3H/Hen mice were i.p. inoculated with  
S. pyogenes (emm3 genotype) clinical isolates (non-sTss, K33; sTss, 
nIH34; 3.0×107 CFu per mouse), and plasma cytokine levels were 
determined by FlowCytomix. Data are expressed as mean ± s.d. for at  
least 2 independent experiments, using a total of 6–10 mice for each 
group. The differences compared with K33-infected mice were statistically 
significant (*P < 0.05, **P < 0.01) as determined by student’s t-test.  
(b) C3H/Hen mice were i.p. inoculated with nIH34 (3.0×107 CFu per 
mouse) in the presence of an IFn-γ neutralizing mAb (clone R4-6A2) (1 mg 
per mouse) or control rat IgG (1 mg per mouse). survival was observed for 
4 days post-infection. mortality differences compared with infected mice 
in the presence of control IgG were statistically significant (*P < 0.05), as 
determined by a log-rank test. survival curves were generated from two 
independent experiments, using a total of eight mice for each group.ARTICLE     
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throughout infection (Supplementary Fig. S1). By contrast, TCR-β +  
T cells and DX5 +  or NK1.1 +  NK cells, which are regarded as the 
sources of IFN-γ in GAS infections15–17, produced small amounts 
of IFN-γ during the late stage (days 3–5 post-infection) of severe 
invasive GAS infections in C3H/HeN mice, but not in C57BL/6 
mice. Notably, the accumulation of Gr-1 +  cells led to the clearance 
of infection from the spleen. Additionally, the administration of 
monensin, which blocks intracellular cytokine transport, did not 
induce spontaneous splenic production of IFN-γ (Fig. 2a and b; 
Supplementary Fig. S1).
To  exclude  the  involvement  of  T  cells  in  protection  against 
severe invasive GAS infections, we investigated IFN-γ production in 
C57BL/6.RAG1 knockout (Rag1 − / − ) mice, which have no mature 
B and T cells26. The ICS assay revealed that the cellular source of 
IFN-γ during severe invasive GAS infections was Gr-1 +  CD11b +  
cells in Rag1 − / −  mice, and also in C57BL/6 wild-type (WT) mice 
(Fig. 2b). We further examined the mortality of Rag1 − / −  mice dur-
ing  severe  invasive  GAS  infections.  We  observed  no  significant 
difference in mortality between Rag1 − / −  and WT mice infected 
with severe invasive GAS isolates (Fig. 2c). Furthermore, similar to 
C3H/HeN mice (Fig. 1b), IFN-γ neutralizing mAb (clone R4-6A2)-
treated  Rag1 − / −   mice  were  more  susceptible  to  severe  invasive   
GAS infections than were control IgG-administered Rag1 − / −  mice 
(Fig. 2d). Our results indicate that mature B and T cells do not affect 
the mortality of infected mice, and that T cells have no protective 
effect during the early stage of severe invasive GAS infections.
Characterization  of  the  early  source  of  IFN-γ.  Anti-Gr-1 mAb 
detects Ly-6C +  monocytes and Ly-6G +  PMNs. Therefore, to deter-
mine which subset of Gr-1 +  CD11b +  cells is responsible for IFN-γ 
production during severe invasive GAS infections, we investigated 
the surface phenotype of IFN-γ-producing cells isolated from the 
spleens of mice at 48 h post-infection. The ICS assay revealed that 
IFN-γ-producing cells had the phenotype of monocytes (F4/80low 
CX3CR1 + ) and PMNs (Ly-6G +  Ly-6Clow) (Fig. 3). Additionally, 
they expressed no lymphoid (CD27, IL-7Rα) or granulocyte-lineage 
(CCR3, Siglec-F, c-Kit, IL-5Rα (H7)) markers, but exhibited partic-
ular profiles of CCR2 −  CD31 +  CD34 −  CD38 +  CD44high CD49d +  
CD62L +  CD69 +  IL-5Rα (T21)high Siglec-H −  (Fig. 3; Supplemen-
tary Table S1). In this model, the most prominent GAS infection 
was present in the kidney18,27. In accordance with the bacterial bur-
den in the peritoneal cavity, spleen and kidney, a higher proportion 
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Figure 2 | CD11b +  Gr-1 +  cells are the source of IFN-γ in severe invasive GAS infections. (a,b) C3H/Hen mice (a), C57BL per six mice (WT) (b), and 
Rag1 − / −  mice (b) with or without i.p. infection of nIH34 (3.0×107 CFu per mouse) for 42 h were i.v. injected with monensin. six hours later, the mice 
were sacrificed and their splenocytes were immediately stained for the indicated markers, and analysed by ICs assay. (a) The numbers (%) in the plots 
represent the proportion of IFn-γ +  subsets to total splenocytes. (b) Lower panels show the cells gated on the IFn-γ +  population. Data are representative 
of three independent experiments. (c,d) WT and Rag1 − / −  mice were i.p. inoculated with nIH34 (3.0×107 CFu per mouse) in the absence (c) or presence 
(d) of an IFn-γ neutralizing mAb (clone R4-6A2) or control rat IgG (1 mg per mouse) as in Fig. 1b. survival (in days) was observed as indicated. survival 
curves were generated from 2 independent experiments, using a total of 12 mice for each group. (d) mortality differences compared with infected mice in 
the presence of control IgG were statistically significant (*P < 0.05) as determined by a log-rank test.ARTICLE
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of IFN-γ-producing cells accumulated in the kidney of C3H/HeN 
mice, and also C57BL/6 mice i.p. infected with NIH34 (Supplemen-
tary Fig. S2). By contrast, lower proportion of IFN-γ-producing 
cells existed at the sites of infection. A skin-infection model yielded 
similar results (Supplementary Fig. S2). Furthermore, IFN-γ-pro-
ducing cells were detected in the spleens from mice infected with 
various STSS strains18,27 (Supplementary Fig. S3). These cells were 
also detected in the peripheral blood and (in particularly high fre-
quency) the bone marrow from NIH34-infected mice (Fig. 4a–d; 
Supplementary Fig. S4). Interestingly, Siglec-F +  eosinophils (Eos) 
stained with IL-5Rα (H7) and IL-5Rα (T21), whereas IFN-γ-pro-
ducing cells stained well with T21, but not with H7 (Fig. 4e), sug-
gesting  that  IFN-γ-producing  cells  were  phenotypically  distinct 
from Eos. IFN-γ-producing cells were also phenotypically distinct 
from Ly-6Clow CD31 −  PMNs (Fig. 4d). Moreover, the number and 
proportion of PMNs were markedly reduced in the spleen, periph-
eral blood, and bone marrow at 48 h post-infection (Fig. 4d and f), 
as reported in human STSS cases28.
Immature myeloid cells as an early source of IFN-γ. The IFN-γ-
producing cells expressed the phenotypic markers of monocytes/
macrophages (F4/80 and CX3CR1) and PMNs (Ly-6G). Therefore,   
we sorted CD11b +  CD11c −  F4/80low Ly-6G +  cells from the spleens 
of infected mice and morphologically analysed them with May-
Grünwald-Giemsa staining. The IFN-γ-producing CD11b +  CD11c −  
F4/80low  Ly-6G +   splenocytes  were  IMCs,  but  not  monocytes/ 
macrophages or PMNs. These IFN-γ-producing IMCs were large 
cells containing ring-shaped, non-segmented nuclei, with a coarse 
chromatin pattern6–8 (Fig. 5a and b). The sorted cells were contami-
nated with a small number of PMNs; however, immunohistochemical 
analyses showed that IMCs, but not PMNs, were the source of IFN-γ 
(Fig. 5c). The cells with ring-shaped nuclei were also observed in the 
peritoneum, kidney, and spleen from i.p. infection model, and in the 
skin from subcutaneous (s.c.) infection model, whereas such cells 
were not observed in the spleen and kidney from non-infected or 
non-invasive K33 strain-infected mice (Fig. 5d and e). To determine 
whether IFN-γ-producing IMCs (γIMCs) are committed to the gran-
ulocyte or monocyte lineage, we cultured sorted CD11b +  CD11c −  
F4/80low Ly-6G +  γIMCs in vitro, in the presence of G-CSF, M-CSF, 
GM-CSF or IL-5. We observed that G-CSF, M-CSF and IL-5 failed 
to promote differentiation and survival (Fig. 5f). By contrast, in the 
presence of GM-CSF, differentiated γIMCs increased their expres-
sion of CD11c, F4/80, DX5 and Siglec-F (Fig. 5g) with the polymor-
phonuclear phenotype (Fig. 5h). Such granulocyte-like cells showed 
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Figure 3 | IFN--producing cells exhibit monocyte and PMN phenotypes in severe invasive GAS infections. C3H/Hen mice with or without i.p. 
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reduced ability to produce IFN-γ (Fig. 5i), and were phenotypically 
different from c-Kitlow H7 +  Siglec-F +  bone marrow-derived Eos 
and CCR3 +  H7 +  Siglec-F +  splenic Eos29; (Supplementary Fig. S5). 
These results suggest that γIMCs are committed to the granulocyte 
lineage, but do not exist in the steady state, and produce IFN-γ  
during a specific stage of differentiation.
Nitric oxide (NO) is considered to be a main mechanism for 
controlling some infective agents. Myeloid cells are able to release 
NO in response to IFN-γ30–33; moreover, IFN-γ and NO-producing 
myeloid cells have been described in cancer34. Therefore, we inves-
tigated the ability of γIMCs to produce NO in response to GAS. 
When  stimulated  by  autocrine  and/or  paracrine  IFN-γ,  γIMCs 
(but not than PMNs and granulocyte-like cells differentiated from 
γIMCs using GM-CSF) were able to produce NO, because their 
NO production was significantly blocked in the presence of IFN-γ  
neutralizing mAb (Fig. 5j).
Differentiation of precursor-like cells into γIMCs. Bone marrow 
contains the highest proportion of γIMCs (Fig. 4c and d). Therefore, 
we attempted to identify the precursors of γIMCs in the bone mar-
row of mice infected with severe invasive GAS isolates. Interestingly, 
analysis of the surface molecules revealed 2 distinct subsets of IFN-
γ-producing cells (Fig. 6a): a minor and a major subset. The minor 
subset constituted 6.9 ± 3.2% of IFN-γ-producing bone marrow cells 
(Fig. 6b), and comprised CD11b +  CD11c −  F4/80low Ly-6G +  large 
cells (Supplementary Fig. S6), containing ring-shaped nuclei (BM-
γIMCs) (Fig. 6c). On the basis of morphology and surface pheno-
type, these cells corresponded to splenic γIMCs (Sp-γIMCs) (Fig. 5a 
and b). Neither isolated BM-γIMCs nor Sp-γIMCs proliferated in 
the presence of GM-CSF (Figs 5f and 6d). These cells differed from   
metamyelocytes and immature neutrophils in non-infected bone 
marrow (Fig. 6c). The major subset of IFN-γ-producing cells com-
prised  CD11b +   CD11clow  F4/80 +   Ly-6Glow  precursor-like  cells 
(BMPCs)  (Fig.  6b;  Supplementary  Fig.  S6),  which  constituted 
74.8 ± 13.7% of IFN-γ-producing cells (Fig. 6b). This subset con-
sisted of ~10% monocyte-like ring cells and immature myeloid cells 
(Fig. 6c), which are phenotypically different from CD11b −  Ly-6G −  
cells such as granulocyte–monocyte progenitors, common myeloid 
progenitors,  and  myelolymphoid  progenitors35.  In  the  presence 
of GM-CSF, isolated BMPCs proliferated (Fig. 6d) and differenti-
ated into BM-γIMCs (Fig. 6c and e). Moreover, after 2 extra days of 
incubation with GM-CSF, differentiated BM-γIMCs increased their   
expression of CD11c, F4/80, DX5 and Siglec-F (Fig. 6f). The polymor-
phonuclear and cell surface phenotype (Supplementary Fig. S6) was 
similar to that of Sp-γIMCs cultured with GM-CSF (Fig. 5g and  h). The   
differentiation of BMPCs into BM-γIMCs was totally blocked in the 
presence of IFN-γ neutralizing mAb; by contrast, this cytokine was 
dispensable for differentiation into granulocyte-like cells (Supple-
mentary Fig. S6). These results are in accordance with the absence of 
Ly-6G +  γIMCs in the spleen of GAS-infected C57BL6.Ifng − / −  mice 
(Supplementary Fig. S7). The expression level of Ly-6G in PMNs 
was similar for WT and Ifng − / −  mice (Supplementary Fig. S7). As 
with γIMCs and γIMC-differentiated granulocyte-like cells (Fig. 5i), 
the cells differentiated from BMPCs, after 2 extra days of incuba-
tion with GM-CSF, retained the ability to release IFN-γ in response 
to GAS; however, subsequent differentiation by GM-CSF reduced 
the  ability  to  produce  IFN-γ  (Fig.  6g).  A  few  IFN-γ-producing   
cells in non-infected mice were recognized in the same fraction as 
the BMPCs (Fig. 6a), and, therefore, it is possible that BMPCs exist 
in the naïve bone marrow. Our results suggest that IFN-γ-producing 
BMPCs are the precursors of γIMCs, and that their differentiation   
is  dependent  on  autocrine  and/or  paracrine  pathways  involving   
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IFN-γ.  Notably,  the  BMPC-derived  unclassified  granulocyte- 
lineage, such as γIMCs (but not immature PMNs), seems to appear 
during severe invasive GAS infections.
Distinction between γIMCs and MDSCs. MDSCs are composed of 
F4/80 −  or F4/80low granulocytic MDSCs with ring-shaped nuclei, 
and F4/80 +  monocytic MDSCs10,11. They can produce IFN-γ13. 
Furthermore,  granulocytic/monocytic  MDSCs  differentiate  into 
CD11c +  F4/80 +  Gr-1 +  cells12, as do γIMCs (Fig. 5g). To identify 
the relationship between the types of γIMCs observed during severe 
invasive GAS infections and MDSCs, we investigated the ability of 
γIMCs to suppress T-cell responses. As reported previously, in vitro-
differentiated  Ly-6C +   Ly-6Glow  F4/80 +   MDSCs9  spontaneously 
produced IFN-γ (Fig. 7a), and inhibited Ag-specific T-cell prolifera-
tion and IFN-γ production from T cells (Fig. 7b). Conversely, puri-
fied γIMCs failed to inhibit T-cell responses (Fig. 7c), suggesting that 
γIMCs are functionally distinct from MDSCs. Additionally, MDSCs 
markedly decreased in number and lost the ability to produce IFN-γ 
when cultured in vitro with severe invasive GAS isolates (Fig. 7a). 
Furthermore, CCR2 −  CX3CR1 +  CD31 +  γIMCs are phenotypically 
different from CCR2 +  CX3CR1 −  CD31 −  granulocytic MDSCs and 
CCR2high CX3CR1 −  CD31 +  monocytic MDSCs (Supplementary 
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Table S1). Taken together, our results indicate that γIMCs, which 
appear in association with severe invasive GAS infections, comprise 
a novel subset of IFN-γ-producing cells, but not MDSCs.
Role of γIMCs in severe invasive GAS infections. To elucidate 
the protective role of γIMCs, we employed an adoptive transfer 
system using WT or Ifng − / −  mice. CD11b +  CD11c −  F4/80low Ly-
6G +  γIMCs were purified from the spleens of WT mice infected 
with severe invasive GAS at day 2, and transferred into recipient 
mice. These mice were infected with a lethal dose of severe invasive 
GAS isolates (5×107 CFU (high dose)/WT mouse, 1×107 CFU (low 
dose)/Ifng − / −  mouse), and the bacterial loads (CFUs) in the blood 
were quantified. At 24 h post-infection, γIMC-recipients and IFN-
γ-treated mice had significantly lower bacterial loads in the blood 
than did control mice (Fig. 8a–c). Additionally, all control mice and 
all IFN-γ-treated mice died. By contrast, 100% of high dose-infected 
WT recipients and low dose-infected Ifng − / −  recipients of γIMCs, 
and  also  low  dose-infected  WT  mice,  survived  until  60 h  post-
infection (Fig. 8d–f). Our results indicate that IFN-γ successfully 
improved the bacterial clearance, but that systemic IFN-γ treatment 
was  detrimental  to  survival  following  GAS  infections  (Fig.  8a,c,d   
and f). Thus, it appears that γIMCs have a protective role in severe 
invasive GAS infections.
Discussion
Previous studies have indicated that T cells and NK cells may have a 
role in the production of IFN-γ during GAS infections5,15–17,19–21. 
In the present study, we have demonstrated for the first time that 
γIMCs  in  the  peritoneal  cavity,  skin,  spleen,  kidney,  peripheral 
blood and bone marrow (but not T cells or NK cells) produce IFN-
γ in vivo during the early stage of severe invasive GAS infections. 
The intensity of IFN-γ production is comparable among γIMCs, 
T cells, and NK cells, but production by γIMCs takes place sooner 
than that by T cells and NK cells. Moreover, throughout the course 
of GAS infection, γIMCs are the main IFN-γ-producing cells in 
the  spleen.  We  further  observed  that  IFN-γ  neutralized  Rag − / −  
mice succumbed to severe GAS infection at a similar rate to WT 
mice.  Taken  together,  our  results  indicate  that  γIMCs  comprise   
the major source of IFN-γ during the early stage of severe invasive 
GAS infections, and that they have an important protective role.
Notably,  IFN-γ  administration  reduced  the  number  of  bacte-
ria in the blood, whereas the transfer of γIMCs, but not of IFN-γ, 
Blue: GM2-BMPCs
Red: GM4-BMPCs
Green: GM2-BM-γIMCs
C
e
l
l
 
n
u
m
b
e
r
 
(
×
1
0
6
 
m
l
–
1
)
0
0.5
1
1.5
2
0 2 4 6
Days
Non NIH34
F4/80
BMPCs
BM-γIMCs
PMNs
16 65
85
4.7
11
43
74
0.8 
0
20
40
60
80
100
0
20
40
60
80
100
%
 
T
o
 
I
F
N
-
γ
 
+
 
B
M
 
c
e
l
l
s
%
 
T
o
 
B
M
 
c
e
l
l
s
BMPCs
L
y
-
6
G
F4/80
CD11c F4/80 CD11b
Ly-6G DX5
BMPCs
BM-γIMCs PMNs
**
**
**
*
NIH34
BMPCs
0
50
100
150
I
F
N
-
γ
 
(
p
g
 
m
l
–
1
)
– + – +
GM2-
BMPCs
NIH34
*
GM4-
BMPCs
104
104
103
103
102
102
101
101
100
104
103
102
101
100
100 104 103 102 101 100
104
104
103
103
102
102
101
101 100
104
103
102
101
100
104
103
102
101
100
104
103
102
101
100
100 101 102 103 104 100 101 102 103 104 100 101 102 103 104
104
103
102
101
100
100 104 103 102 101 100
GM2-BMPCs
BM-γIMCS
BMPCs
L
y
-
6
G
IFN-γ
+
BM-γIMCs
Siglec-F
GM2-BMPCs
Figure 6 | BMPCs differentiate into γIMCs in the presence of GM-CSF. (a) C3H/Hen mice non-infected or i.p. infected with nIH34 (3.0×107 CFu per 
mouse) for 42 h were i.v. injected with monensin. six hours later, the mice were killed and their bone marrow cells were immediately stained for the 
indicated markers, and analysed by ICs assay. Lower panels show the cells gated on the IFn-γ +  population. The numbers (%) in the plots represent  
the proportion of Pmns, Bm-γImCs, and BmPCs to total (upper panels) and IFn-γ +  (lower panels) bone marrow cells. (b) Proportion (%) of Bm-
γImCs and BmPCs to bone marrow cells (upper panel) or IFn-γ-producing bone marrow cells (lower panel). Data are expressed as mean ± s.d. (n = 3). 
The differences compared with the proportion of Bm-γImCs were statistically significant (**P < 0.01) as determined by student’s t-test. (c) Cytospin 
preparations of sorted Pmns, Bm-γImCs, BmPCs, and Gm-CsF (2 days)-cultured BmPCs (Gm2-BmPCs) were visualized with may-Grünwald-Giemsa 
staining. Arrowheads indicate stab neutrophils or metamyelocytes. scale bars, 20 µm. (d) sorted BmPCs and Bm-γImCs were cultured with Gm-CsF 
(10 ng ml − 1) for 2–6 days, and their absolute numbers were counted on the indicated days. Data are expressed as mean ± s.d. (n = 3). The differences  
in proliferation increase were statistically significant (*P < 0.05, **P < 0.01) as determined by student’s t-test. (e) Flow cytometry profile of infected  
bone marrow cells (left), sorted BmPCs (middle), and Gm2-BmPCs (right). Rectangles show a sorting gate of BmPCs. (f) Gm-CsF-cultured BmPCs  
(2 days or 4 days; Gm2-BmPCs, blue line; Gm4-BmPCs, red line) and Bm-γImCs (2 days; Gm2-Bm-γImCs, green line) were stained for the indicated  
markers. Data are representative of 3 independent experiments. (g) IFn-γ production from BmPCs. Gm2-BmPCs or Gm4-BmPCs were cultured with  
erythromycin-treated nIH34 (moI 100) in the presence of control rat IgG or an IFn-γ neutralizing mAb (clone R4-6A2) for 24 h. The level of IFn-γ in the 
culture supernatants was measured by ELIsA. The average (mean ± s.d.) of triplicate wells is shown. statistical significance (*P < 0.05) was determined  
by student’s t-test.ARTICLE

nATuRE CommunICATIons | DoI: 10.1038/ncomms1677
nATuRE CommunICATIons | 3:678 | DoI: 10.1038/ncomms1677 | www.nature.com/naturecommunications
© 2012 Macmillan Publishers Limited. All rights reserved.
improved the survival rate of mice following GAS infection. There-
fore, IFN-γ was necessary, but not sufficient, to protect mice from 
severe invasive GAS infections. We propose that NO production 
from γIMCs (which is restrictively controlled by IFN-γ), perhaps 
combined with that from other myeloid cells, may have a critical 
defensive role during the early stage of infection. In systemic GAS 
infection,  γIMCs  are  deployed  in  various  infected  tissues;  thus, 
the derived IFN-γ, NO, and/or as yet unidentified protective fac-
tors may promote the development of innate immune responses for   
the activation of phagocytes. However, we were unable to exclude 
the  possibility  that  excessive  quantities  of  IFN-γ  secreted  by   
T cells following superantigens stimulation, by NK cells, and even 
by γIMCs at the late stage of infection, are detrimental to survival 
following GAS infections, by exacerbating inflammatory responses 
and organ injury.
γIMCs express phenotypic markers of the monocyte/macrophage 
and  granulocyte  lineages,  and  are  phenotypically  different  from 
other  Ly-6C +   cells,  such  as  inflammatory  and  resident  mono-
cytes11,36. Mature PMNs, immature PMNs, and their progenitors 
proliferate or maintain their survival in the presence of G-CSF37. 
By contrast, in the present study, γIMCs did not survive in the pres-
ence of G-CSF. However, in the presence of GM-CSF, they differen-
tiated into a PMN-like phenotype. Thus, γIMCs are distinct from 
the PMN lineage that develops during steady-state haematopoiesis. 
In the presence of GM-CSF, γIMCs possessed the ability to express 
a specific marker for Eos, Siglec-F. Nevertheless, based on staining 
with H7 and T21, they were distinct from Siglec-F +  splenic Eos. Our 
observation that γIMCs failed to proliferate in response to IL-5 are 
consistent with the previous finding that T21 mAb may recognize 
IL-5Rα and other myeloid cell surface protein(s)38. Thus, γIMCs   
are  unlikely  to  be  committed  to  an  Eos  lineage;  similarly,  they   
are  phenotypically  different  from  DX5 +   basophils  and  basophil   
lineage-committed progenitors39.
Granulocytic MDSCs are very similar to γIMCs in terms of sur-
face markers (CD11b, F4/80, Ly-6C, Ly-6G, CD44, CD49d, and 
CD62L)10,11,  dependency  on  a  growth  factor  (GM-CSF)12,  and 
cytokine  production  profile  (IFN-γ)13.  However,  in  the  present 
study, we reveal that MDSCs did not produce IFN-γ in response to 
in vitro GAS infections. This is consistent with the previous finding 
that MDSCs from septic mice did not produce IFN-γ40. MDSCs are 
believed to originate from, or be accelerated by, the blockade of nor-
mal haematopoiesis during chronic inflammation or in a tumour-
bearing state. γIMCs and MDSCs may therefore be closely related 
cell  populations,  and  their  differentiation  and  function  may  be   
regulated by the host circumstances.
On the basis of our present findings, we conclude that γIMCs 
are committed to an unclassified granulocyte lineage with an imma-
ture phenotype, and that such cells have the potential to replenish 
granulocyte populations. Moreover, GM-CSF is essential for the 
extraordinary state, such as severe systemic infection, but not for 
normal haematopoiesis41. The replacement of GM-CSF-dependent 
γIMCs may be regarded as a marked shift to the left of the leuko-
cyte differential, with many immature granulocytes in automated 
cell counting. This is a characteristic of severe invasive GAS infec-
tions in our mouse model and also in human diseases4,28. The role 
of γIMCs in other infections and inflammatory diseases remains to 
be elucidated.
In the present study, we reveal that γIMCs differentiate from a 
subpopulation of CD11b +  CD11clow F4/80 +  Ly-6Glow cells in the 
bone marrow; this is known as a monocyte lineage. No γIMCs were 
detected in Ifng − / −  mice infected with GAS, and IFN-γ-producing 
BMPCs (but not γIMCs) failed to differentiate into granulocyte-like 
cells in the presence of an IFN-γ neutralizing mAb. These observa-
tions suggest that the generation of γIMCs depends on the produc-
tion of IFN-γ by BMPCs themselves. IFN-γ derived from BMPCs 
and  γIMCs  may  be  a  key  component  of  haematopoiesis  during 
innate and adaptive immune responses, as shown in cases of malaria 
and Mycobacterium avium infection35,42. In the steady state, a few 
IFN-γ-producing  cells  existed  in  the  Ly-6Clow  CD31 +   fraction, 
including  mixed  progenitors  of  bone  marrow43.  Thus,  we  can-
not exclude the possibility that BMPCs exist in non-infected bone   
marrow and have potential to produce IFN-γ, and that a subset 
of bone marrow cells can produce IFN-γ for the reproduction of   
haematopoietic stem cells42.
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Ring cells are present in the blood and bone marrow of humans, 
especially  patients  with  chronic  myeloproliferative  diseases6–8 
but only rarely in healthy control subjects7. Further investigations   
of peripheral blood leukocytes or bone marrow cells from severe 
invasive GAS patients are required, to clarify whether the human 
counterpart of γIMCs is a major source of IFN-γ in STSS patients.
PMNs  are  known  to  be  essential  for  protection  against  non- 
invasive  streptococcal  infections.  Following  infection  with  severe 
invasive strains, PMNs are impaired by enhanced virulence factors 
(for  example,  streptolysin  O)18,27,  and  therefore  other  protective 
mechanisms are required for the recovery. The results of our present 
study indicate that γIMCs, a novel class of differentiated granulocytic 
ring cells, which comprise the major source of IFN-γ during the early 
phase of severe invasive GAS infections, may have an important role. 
During the later stage of infection, IFN-γ derived from T cells and 
NK cells may be detrimental to the host. Nevertheless, we believe 
that  the  orchestrated  regulation  of  γIMCs  serves  as  a  protective 
mechanism against severe invasive bacterial infections.
Methods
Bacterial strains. The STSS criteria in this study are based on those proposed by 
the Working Group on Severe Streptococcal Infections44. The clinical isolates from 
STSS (NIH34 (emm3 genotype], NIH230 (emm49 genotype), NIH186 (emm1 gen-
otype), and NIH202-2 (emm1 genotype)), and also from non-invasive infections 
(K33 (emm3 genotype)), were collected by the Working Group for Beta-hemolytic 
Streptococci in Japan18,27.
Mice. All work performed using mice was carried out in accordance with the 
guidelines for animal care approved by National Institute of Infectious Diseases. 
C3H/HeN and C57BL/6 mice (male, 5–6-weeks-old) were purchased from SLC. 
C57BL/6.Rag1 − / −  (ref. 26) and C57BL/6.Ifng − / −  (ref. 45) mice were purchased from 
the Jackson Laboratory. All mice were maintained in a specific pathogen-free condition.
GAS infections in a mouse model. GAS were grown to late-log phase (OD600 =  
0.75–0.95). Then, 1.0×107 CFU to 5.0×107 CFU GAS, suspended in 0.5 ml PBS, 
were i.p. inoculated into 6–8-week-old male mice. In some experiments, mice were 
i.p. administered with 1 mg of an anti-mouse IFN-γ neutralizing mAb (clone R4-
6A2) or control rat IgG, or 10 ng of recombinant mouse IFN-γ (Wako Pure Chemi-
cal Industries) at infection. Plasma production of CXCL10 (an IFN-γ-inducible 
protein) at 24 h, after NIH34 infection, was used to assess the activity of inoculated 
IFN-γ (10 ng per mouse) in Ifng − / −  recipients (Ifng − / −  mice, 230.1 ± 58.2 pg ml − 1; 
IFN-γ-treated Ifng − / −  mice, 468.2 ± 147.2 pg ml − 1*; C57BL/6 mice as positive 
control, 460.6 ± 126.9 pg ml − 1*). Data were expressed as mean ± s.d. (n = 5). The 
differences compared with Ifng − / −  mice were statistically significant (*P < 0.05) as 
determined by Student’s t-test. Survival curves were compared using a log-rank test.
Measurement of cytokines in plasma. The plasma cytokine levels were deter-
mined by FlowCytomix (eBioscience) using a FACSCalibur flow cytometer (Becton,   
Dickinson and Company (BD)), according to the manufacturer’s instructions.
Flow cytometry analysis. For the in vivo ICS assay22,23, at day 2 post-infection, 
mice were intravenously (i.v.) injected with 500 µl of a PBS solution containing 
100 µg monensin (Sigma-Aldrich) at 6 h before collecting. Splenocytes, peripheral 
blood cells, bone marrow cells, and leukocytes in the peritoneal cavity, kidney, 
and skin were collected and rapidly processed on ice. Single-cell suspensions were 
prepared, and red blood cells were removed using an ammonium chloride lysis 
buffer. For the in vitro ICS assay, non-infected or infected cells were cultured with 
10 µg ml − 1 brefeldin A (Sigma-Aldrich) for 3 h. One million cells were stained 
with Alexa Fluor 488-, FITC-, PE-, Alexa Fluor 647-, allophycocyanin (APC)-, or 
Pacific Blue-conjugated Abs (clones and suppliers, Supplementary Table S2) at 4 °C 
for 15 min. Nonspecific staining was blocked with an anti-mouse FcγR mAb (clone 
2.4G2). Dead cells were excluded by 7-aminoactinomycin D (7-AAD; Sigma-
Aldrich) staining. After washing, cells were fixed in 2% paraformaldehyde/PBS for 
10 min and then permeabilized in 0.5% saponin/0.5% BSA/PBS (permeabilization 
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Figure 8 | IMCs participate in protection against severe invasive GAS infections. (a–f) CD11b +  CD11c −  F4/80low Ly-6G +  γImCs in the spleen from 
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buffer), before being stained with a PE- or APC-conjugated anti-mouse IFN-γ mAb 
(clone XMG1.2; eBioscience) or isotype control Ab (eBioscience) for 45 min at 4 °C. 
Cells were washed, first with permeabilization buffer, then with FACS buffer, before 
being applied to a FACSCalibur or FACSAria flow cytometer (BD). Analyses were 
performed using FlowJo software (Ashland, OR).
Cytological analysis. Fifty thousand cells were subjected to a cytospin (Thermo 
Shandon). For morphological analysis, the cytospin preparations were fixed with 
methanol and visualized with May-Grünwald-Giemsa staining. For intracellular 
IFN-γ staining, the cytospin preparations were fixed with 2% paraformaldehyde 
for 10 min, treated with 50 mM NH4Cl/PBS for 15 min, and blocked with an 
anti-mouse FcγR mAb (clone 2.4G2) in permeabilization buffer for 15 min. Slides 
were stained with an APC-conjugated anti-mouse IFN-γ mAb (clone XMG1.2) or 
isotype control Ab (eBioscience) for 45 min, washed 3 times with permeabilization 
buffer, and then washed 3 times with PBS. Nuclei were visualized with propidium 
iodide staining. Samples were viewed and photographed with a Carl Zeiss LSM510 
confocal laser scanning microscope.
Histology. For histological analysis, the tissues from GAS-infected mice were 
fixed in 10% formalin/PBS. The paraffin-embedded sections were stained with 
hematoxylin and eosin.
In vitro culture of γIMCs and BMPCs. Purified CD11b +  CD11c −  F4/80low  
Ly-6G +  γIMCs and CD11b +  CD11clow F4/80 +  Ly-6Glow BMPCs from GAS- 
infected (monensin-untreated) mice were cultured at 0.5×106 cells per ml in  
medium containing RPMI 1640 (Wako) with 10% FBS (Nichirei), 100 U ml − 1 
penicillin, 10 µg ml − 1 streptomycin, 2 mM glutamine, 25 mM HEPES, and 50 µM 
2-ME, with or without 10–50 ng ml − 1 recombinant mouse GM-CSF, G-CSF,  
M-CSF, or IL-5 (R&D Systems), in the presence or absence of 1 µg ml − 1 control rat 
IgG or R4-6A2, for 2–6 days. On days 2 and 4, 50% of the medium was replaced 
with fresh medium, or the cells were collected for May-Grünwald-Giemsa stain-
ing and flow cytometry analysis. In some experiments, the cells were cultured at 
0.5×106 cells ml − 1 with 25 µg ml − 1 erythromycin and NIH34 (MOI 100) in 10% 
FBS/phenol red-free RPMI medium, supplemented with 10 ng ml − 1 GM-CSF, in 
the presence of 1 µg ml − 1 control rat IgG or R4-6A2 for 24 h. The levels of IFN-γ 
and NO in the culture supernatants were measured by an instant ELISA kit  
(eBioscience) and a Griess reagent (Wako), respectively, according to the  
manufacturer’s instructions.
In vitro culture of Eos and MDSCs. For obtaining Eos, naïve bone marrow cells 
were cultured in 10% FBS/RPMI medium supplemented with stem cell factor 
(PeproTech) and FLT3-ligand (PeproTech) for 4 days, and then with medium 
containing recombinant mouse IL-5 (R&D Systems). On day 12, the cells were 
collected for May-Grünwald-Giemsa staining and flow cytometry analysis46. To 
isolate bone marrow-derived MDSCs, naïve bone marrow cells were cultured at 
1.0×106 cells per ml in 10% FBS/RPMI medium, supplemented with 40 ng ml − 1 
GM-CSF. On day 4, the cells were collected for FACS analysis of CD11b +  CD11c −  
Ly-6C +  Ly-6Glow MDSCs9.
Ag-specific T-cell proliferation and IFN-γ production. The Ag-specific pro-
liferation of CD8 +  T cells was evaluated using OT-I OVA-specific MHC Class 
I-restricted TCR transgenic mice. Varying amounts of purified CD11b +  CD11c −  
F4/80low Ly-6G +  γIMCs from infected C57BL/6 mice at 2 days post-infection, or 
bone marrow-derived F4/80 +  Ly-6C +  Ly-6Glow MDSCs, were added to 2.0×105 
naïve splenocytes from OT-I mice in medium containing RPMI 1640 with 10% 
FBS in a U-bottom 96-well plate. These co-cultures were stimulated with antigenic 
OVA357–364 peptides (10 µM) for 4 days. Proliferation of OT-I cells in triplicate was 
estimated by the incorporation of [3H] thymidine (1 µCi (0.0037 MBq) per well), 
added at 18 h before cell harvest. The level of IFN-γ in the culture supernatants was 
measured by an instant ELISA kit (eBioscience), according to the manufacturer’s 
instructions.
Adoptive transfer of γIMCs. CD11b +  CD11c −  F4/80low Ly-6G +  γIMCs in 
splenocytes from Ifng + / +  mice infected with NIH34 (3.0×107 CFU) for 48 h were 
isolated with a FACSAria flow cytometer. Recipient mice were i.v. administered 
with purified CD11b +  CD11c −  F4/80low Ly-6G +  γIMCs (3.0×106 cells), and  
i.p. inoculated with NIH34 (1.0×107 CFU to 5.0×107 CFU) on the same day.
Measurement of bacterial loads. At 24 h post-infection, 20 µl of peripheral 
blood was removed from the tail vein by phlebotomy. The blood was diluted at 
1:10–1:1000 with PBS and spread on a Columbia agar plate containing 5% sheep 
blood (BD). To determine the number of NIH34 in peripheral blood, the plates 
were incubated for 20 h at 37 °C in a 5% CO2 atmosphere, and the colonies were 
counted. The number of NIH34 was compared statistically using the Mann– 
Whitney U-test. 
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